The optimization of continuous ambulatory peritoneal dialysis
نویسندگان
چکیده
منابع مشابه
The optimization of continuous ambulatory peritoneal dialysis.
medication, but he required medication thereafter. He had no episodes of peritonitis and gained 5 kg. However, his urine output gradually declined despite large doses of furosemide. At the beginning of the third year, despite an increasing dose and number of antihypertensive medications, he complained of progressive fatigue, anorexia, and ankle swelling. He was hypertensive (blood pressure, 180...
متن کاملPaediatric continuous ambulatory peritoneal dialysis.
Ten children in end-stage renal failure were treated by continuous ambulatory peritoneal dialysis (CAPD). This represents a total of 3.4 patient years. Biochemical control was good, and parent and patient acceptability high. Peritonitis was the chief complication, but after the institution of a specific CAPD education and training programme the incidence declined 10-fold. We regard CAPD as an e...
متن کاملThe peritoneal immune system and continuous ambulatory peritoneal dialysis.
Continuous ambulatory peritoneal dialysis (CAPD) has been an established treatment for end-stage renal disease for about 20 years. A major problem of CAPD is the relatively high incidence of peritonitis, and this fact has served as a stimulus to nephrologists to study the immune mechanisms of the peritoneum. It is by now well established that all three main cell systems present in the peritonea...
متن کاملCurrent problems in continuous ambulatory peritoneal dialysis
In spite of multiple problems, continuous ambulatory peritoneal dialysis is now an acceptable alternative treatment for end-stage renal failure. With proper care and attention to detail, many of its problems can be reduced or eliminated. It is particularly suitable for the very old, the very young and the patient living a long distance from the centre, and it is the treatment of choice for diab...
متن کاملAmikacin pharmacokinetics during continuous ambulatory peritoneal dialysis.
The pharmacokinetics of amikacin were investigated in five stable patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Each patient was studied after the administration of 7.5 mg of amikacin per kg by both the intravenous (i.v.) and intraperitoneal (i.p.) route, allowing a 1-month washout period between doses. No differences in amikacin half-life, volume of distribution, total ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Kidney International
سال: 1999
ISSN: 0085-2538
DOI: 10.1046/j.1523-1755.1999.0550031131.x